TRANSURETHRAL LASER EN BLOC RESECTION OF THE BLADDER IN THE TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER
Abstract
Bladder cancer is a common disease in the world and the Russian Federation. The most common is its non-muscle invasive form, the main treatment of which is transurethral resection of the bladder followed by intravesical chemotherapy. The peculiarity of this operation is the gradual removal of the tumor, which leads to a fragmented histological specimen and various complications in the postoperative period. Transurethral removal of a bladder tumor using an en-bloc method, is not inferior to traditional surgery in terms of results and has some advantages over traditional surgery, namely in reducing intra- and postoperative complications, obtaining a high-quality specimen for histological examination. The use of holmium and thulium lasers for the en-bloc removal of a bladder tumor provides additional advantages in treatment outcomes.
The review presents world data on the possibilities of using the surgical method and the use of modern lasers in transurethral resection of the bladder using the en-bloc method.
About the Authors
V. N. DubrovinRussian Federation
G. M. Khasanova
Russian Federation
R. T. Murzabaeva
Russian Federation
A. M. Mukhametzyanov
Russian Federation
G. A. Mavzyutova
Russian Federation
A. M. Pushkarev
Russian Federation
A. V. Tutelyan
Russian Federation
References
1. Sostojanie onkologicheskoj pomoshhi naseleniju Rossii v 2020 godu (State of oncological care in Russia in 2020). Pod red. A.D. Kaprina, V.V. Starinskogo, A.O. Shahzadovoj. - M.: MNIOI im. P.A. Gercena, filial FGBU «NMIC radiologii» Minzdrava Rossii, 2021:239. (in Russ).
2. Babjuk M. [et al.] European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)/ Eur. Urol. 2022;81: 75–94.(in Engl).
3. Kramer M. [et al.] Evidence of Transurethral En-bloc Resection of Nonmuscle Invasive Bladder Cancer. Eur. Urol. Focus. 2017; 3:567–576. (in Engl).
4. Gregg J. [et al.] Short term complications from transurethral resection of bladder tumor. The Canadian Journal of Urology. 2016;23:8198-8203. (in Engl).
5. Mariappan H., Zachou P. A., Grigor K. Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. European Urology. 2010; 57:843-849. (in Engl).
6. He D. [et al.] Novel green-light KTP laser en bloc enucleation for nonmuscle invasive bladder cancer: Technique and initial clinical experience. Journal of Endourology. 2014; 28(8):975-979. (in Engl).
7. Kim L., Patel M. Transurethral resection of bladder tumour (TURBT). Transl Androl Urol. 2020; 9(6):3056–3072. (in Engl).
8. Hurle R. [et al.] “En bloc” resection of nonmuscle invasive bladder cancer: a prospective single-center study. Urology. 2016; 90:126-130. (in Engl).
9. Okada Y. [et al.] Visualizing the muscularis propria via narrow band imaging during transurethral en bloc dissection for non-muscle-invasive bladder cancer. European Urology, Supplements.2016;15(3):204-213. (in Engl).
10. Kawada T., Ebihara K., Yamanaka H. A new technique for transurethral resection of bladder tumors: rotational tumor resection using a new arched electrode. J Urol. 1997;157: 2225–2226. doi: 10.1016/S0022-5347(01)64724-4. (in Engl).
11. Мартов А.Г. [и др.] Трансуретральное удаление опухолей мочевого пузыря единым блоком. Онкоурология. 2015;1:41-49. (in Engl).
12. Daniel G., Roumiguie M., Fons P. En bloc bipolar resection to optimize TURB samples for organotypic culture and development of targeted treatments in non-muscle invasive bladder cancer. European Urology. 2016;15(3):1039-1047. (in Engl).
13. Hurle R. [et al.] Long-term follow-up in high risk non muscle invasive bladder cancer (NMIBC) «en-bloc» resection. European Urology Supplements. 2018; 17(2): 1063-1071.
14. Teichmann H. [et al.] Technical aspects of lasers in urology. World J Urol. 2007;25(3):221−225. doi: 10.1007/s00345-007-0184-5. (in Engl).
15. Gilling P. [et al.] Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7 years. BJU Int. 2012;109(3):408−411. doi: 10.1111/j.1464-410X.2011.10359. (in Engl).
16. Das A., Gilling P., Fraundorfer M. Holmium laser resection of bladder tumors (HoLRBT). Tech Urol. 1998; 4(1):12-14. (in Engl).
17. Enikeev D.V., Glybochko P.V., Alyaev Yu.G., Rapoport L.M., Vinarov A.Z., Enikeev M.E., Sorokin N.I., Spivak L.G., Sukhanov R.B., Dymov A.M., O.Kh. Khamraev, Taratkin M.S., Davydov D.S., Vinnichenko V.A. Current laser technologies for the surgical treatment of prostatic hyperplasia. Urologiia. 2017(1):108-113. DOI: https://dx.doi.org/10.18565/urol.2017.1.108-113 (in Russ).
18. Gao X. [et al.] Thulium laser resection via a flexible cystoscope for recurrent non-muscle-invasive bladder cancer: Initial clinical experi- ence. BJU Int. 2008; 102(9):1115–1118. (in Engl).
19. Geavlete B. [et al.] Medium size bladder tumors' en-block bipolar ablation put to the test-a long term, prospective, randomized- controlled clinical comparison to standard resection. Journal of Urology. 2018;199(4):93-98. (in Engl).
20. Naselli A. [et al.] En bloc transurethral resection of bladder lesions: a trick to retrieve specimens up to 4.5 cm. BJU Int. 2012;109(6):960-963. (in Engl).
21. Enikeev D. [et al.] The changing role of lasers in urologic surgery. Current Opinion in Urology. 2020;30:24-29. (in Engl).
22. Geavlete B. [et al.] Narrow band imaging cystoscopy and bipolar plasma vaporization for large nonmuscle-invasive bladder tumors-results of a prospective, randomized comparison to the standard approach. Urology. 2012;79(4):846–851. https://doi.org/10.1016/j.urology.2011.08.081. (in Engl).
23. Hayashida Y. [et al.] Clinical benefits of combined technique transurethral en-BLOC + endoscopic mucosal resection for non-muscle invasive bladder cancer, especially in large tumor. Journal of Urology. 2017;197(4):902-908. (in Engl).
24. Teoh J. [et al.] En bloc resection of bladder tumour: the rebirth of past through reminiscence. World Journal of Urology. 2023;2: 1-9. https://doi.org/10.1007/s00345-023-04547-0. (in Engl).
25. Naselli A. [et al.] En bloc transurethral resection of bladder lesions: a trick to retrieve specimens up to 4.5 cm. BJU Int. 2012;109(6):960-963. (in Engl).
26. Collado A. [et al.] Early complications of endoscopic treatment for superficial bladder tumors. The Journal of Urology. 2000;164:1532. (in Engl).
27. Mydlo J. [et al.] Long-term consequences from bladder perforation and/or violation in the presence of transitional cell carcinoma: results of a small series and a review of the literature. The Journal of Urology. 1999;161:1128-1132. (in Engl).
28. Babjuk M. [et al.] European association of urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and Carcinoma in Situ). Eur Urol. 2022; 8(1):75–94. https://doi.org/10.1016/j.eururo.2021.08.010. (in Engl).
29. Cumberbatch M. [et al.] Repeat Transurethral Resection in Non–muscle-invasive Bladder Cancer: A Systematic Review. Eur Urol.;73(6):925-933. (in Engl).
30. Naselli A. [et al.] Role of Restaging Transurethral Resection for T1 Non–muscle invasive Bladder Cancer: A Systematic Review and Meta-analysis. Eur Urol Focus. 2018; 4(4):558-567. (in Engl).
31. Kramer M. [et al.] En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor. World J Urol. 2015; 33(12):1937-1943. doi: 10.1007/s00345-015-1568-6. (in Engl).
32. Zhang D. [et al.] Safety and efficacy of en bloc transurethral resection versus conventional transurethral resection for primary non-muscle-invasive bladder cancer: a meta-analysis. World Journal of Surgical Oncology. 2020;18:1776-1784. https://doi.org/10.1186/s12957-019-1776-4 (in Engl).
33. Henglong H. [et al.] A Systematic Review on the Role of Repeat Transurethral Resection after Initial en Bloc Resection for Non-Muscle Invasive Bladder Cancer. J. Clin. Med. 2022;11: е1-17. https://doi.org/10.3390/jcm11175049. (in Engl).
34. Teoh J. [et al.] An international collaborative consensus statement on en bloc resection of bladder tumour incorporating two systematic reviews, a two-round delphi survey, and a consensus meeting. Eur Urol. 2020;78(4):546-569. (in Engl).
35. Sorokin N. I., Enikeev D. V., Dymov A. M., Tsarichenko D. G., Kislyakov D. A., Gololobov G. Yu., Severgina L. O., Rapoport L. M. Safety and efficacy of thulium transurethral en block resection with fiber laser “Urоlaz” for treatment of non-muscle-invasive bladder cancer. Cancer urology. 2018;14(1):144–151. (in Engl).
36. D. Enikeev [et al.] Safety and Short-Term Oncological Outcomes of Thulium Fiber Laser En bloc Resection of Non-Muscle-Invasive Bladder Cancer: A Prospective Non-Randomized Phase II Trial. Bladder cancer. 2020;6(9):201-210. DOI 10.3233/BLC-200275. (in Engl).
37. Diana P. [et al.] Energy source comparison in en-bloc resection of bladder tumors: subanalysis of a single-center prospective randomized study. World J. Urol. 2022;2: 1-7. doi.org/10.1007/s00345-022-04042. (in Engl).
38. Xu J. [et al.] Efficacy and safety of transurethral laser surgery versus transurethral resection for non-muscle-invasive bladder cancer: A meta-analysis and systematic review. Urol Int. 2020;104(9):810–823. (in Engl).
39. Chai Y. [et al.] The efficacy and safety of thulium laser resection of bladder tumor versus standard transurethral resection in patients with non-muscle-invasive bladder cancer: a systematic review and meta-analysis. JOMN. 2021;17(2):32-42. DOI: 10.31083/jomh.2021.023. (in Engl).
40. Niall J. [et al.] Standard transurethral resection versus transurethral laser surgery for bladder cancer: A systematic review and meta-analysis comparing clinical outcomes and complications. J. endour. 2023;37(1-13). https://www.researchgate.net/publication/365330422.
41. Li K. [et al.] A retrospective comparison of thulium laser en bloc resection of bladder tumor and plasmakinetic transurethral resection of bladder tumor in primary non-muscle invasive bladder cancer. Lasers Med. Sci. 2019;34:85–92. (in Engl).
42. Zhang D. [et al.] Safety and efficacy of en bloc transurethral resection versus conventional transurethral resection for primary non-muscle-invasive bladder cancer: A meta-analysis. World J. Surg. Oncol. 2020;18(4):1-12. (in Engl).
43. Xu J. [et al.] Efficacy and safety of transurethral laser surgery versus transurethral resection for non-muscle-invasive bladder cancer: a meta-analysis and systematic review. Urologia Internationalis. 2020;104:810-823. (in Engl).
44. Hashem A. [et al.] Holmium laser en-bloc resection versus conventional transurethral resection of bladder tumors for treatment of non-muscle-invasive bladder cancer: A randomized clinical trial. Eur Urol Focus. 2021;7(5):1035–1043. (in Engl).
45. Long G. [et al.] Safety and efficacy of thulium laser resection of bladder tumors versus transurethral resection of bladder tumors: A systematic review and meta-analysis. Lasers Med Sci. 2021;36(9):1807–1816. (in Engl).
Review
For citations:
Dubrovin V.N., Khasanova G.M., Murzabaeva R.T., Mukhametzyanov A.M., Mavzyutova G.A., Pushkarev A.M., Tutelyan A.V. TRANSURETHRAL LASER EN BLOC RESECTION OF THE BLADDER IN THE TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER. Bashkortostan Medical Journal. 2023;18(5):70-77. (In Russ.)